COVID-19 Vaccine Addressable Market

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content:

1. Introduction
   1. Research Scope
   2. Market Segmentation
   3. Research Methodology
   4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
   1. Market Drivers
   2. Market Restraints
   3. Industry Challenges
   4. Market Opportunities
4. Key Insights
   1. COVID-19 Disease Overview
   2. Epidemiology and Outbreak Analysis of COVID 19 by Key Countries
   3. Comparison of COVID-19 Pandemic with Previous Epidemics Such as SARS and MERS
   4. Steps Being Taken by Governments to Develop aCOVID-19 Vaccine
   5. Key Industry Developments – Collaborations & Partnerships in the Development of COVID-19 Vaccine
   6. Statistics on Ageing Population – For Key Countries
   7. Statistics on Prevalence of Chronic Diseases – For Key Countries
5. COVID-19 Vaccine – Pipeline Assessment
   1. By Technology Platform / Molecule Type
   2. By Recruitment Status
   3. By Study Phase
   4. By Gender
   5. By Study Type
   6. By Sponsor
6. COVID-19 Vaccine - Addressable Market (in Revenues and million doses)
   1. North America
      1. USA
      2. Canada
   2. Europe
      1. UK
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Rest of Europe
   3. Asia Pacific
      1. Japan
      2. China
      3. India
      4. Australia
      5. Rest of APAC
   4. Rest of World
7. Company Profiles (Overview, Products, SWOT, Recent Developments, Strategies, Financials (based on availability))
   1. GlaxoSmithKline plc
   2. Pfizer Inc.
   3. Sanofi
   4. Merck & Co.
   5. Johnson & Johnson Services Inc.
   6. Inovio Pharmaceuticals, Inc.
   7. Moderna Inc.
   8. CanSino Bio-B
   9. Sinovac Biotech Ltd.
   10. BioNTech SE
   11. Others Players